For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Optimizing Monoclonal Antibody Separation using bioZen™ SEC-3 Column
Accurate characterization of monoclonal antibody (mAb) aggregates has huge significance in the development of new therapeutic agents. The introduction of high efficiency UHPLC instruments offering low system dwell volume coupled with sub-2 µm particles has offered significant improvements in the resolution and characterization of aggregates and fragments. In this technical note, four monoclonal antibodies were analyzed using sub-2 µm SEC columns under optimized mobile phase conditions.
Optimizing Monoclonal Antibody Separation using bioZen™ SEC-3 Column
Accurate characterization of monoclonal antibody (mAb) aggregates has huge significance in the development of new therapeutic agents. The introduction of high efficiency UHPLC instruments offering low system dwell volume coupled with sub-2 µm particles has offered significant improvements in the resolution and characterization of aggregates and fragments. In this technical note, four monoclonal antibodies were analyzed using sub-2 µm SEC columns under optimized mobile phase conditions.
Document Type:
Technical Notes
Techniques:
Brands:
Separation Modes:
Size Exclusion
Phases: